Study guide
Section 2.13: Pharmaceutical Calculations: Dilutions and Reconstitution
Saudi Pharmacist Licensure Examination SPLE - Pharmacist
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
Section 0.1: About the Saudi Pharmacist Licensure Examination (SPLE) Section 0.2: How to Study and Prep for the SPLE
2 Chapter 1: Basic Biomedical Sciences
Section 1.1: Human Physiology & Pathophysiology Foundations Section 1.2: Medical Biochemistry & Enzymology Section 1.3: Medical Microbiology & Immunology Section 1.4: Molecular Genetics & Pharmacogenomics Foundations
3 Chapter 2: Pharmaceutical Sciences
Section 2.1: Medicinal Chemistry & Structure-Activity Relationships (SAR) Section 2.2: Drug ADME (Absorption, Distribution, Metabolism, Excretion) Section 2.3: General Pharmacology: Mechanisms of Drug Action Section 2.4: General Toxicology: Overdose, Antidotes & Adverse Drug Reactions (ADRs) Section 2.5: Pharmacognosy: Natural Products & Dietary Supplements Section 2.6: Basic Pharmaceutics & Dosage Form Design Section 2.7: Biopharmaceutics & Drug Delivery Systems Section 2.8: Applied Pharmacokinetics (PK): One-Compartment Models Section 2.9: Non-linear and Multi-compartment Pharmacokinetics Section 2.10: Sterile Compounding: Techniques & Quality Standards Section 2.11: Non-sterile Compounding & Product Formulation Section 2.12: Pharmaceutical Calculations: Dosing and Strengths Section 2.13: Pharmaceutical Calculations: Dilutions and Reconstitution Section 2.14: Pharmaceutical Calculations: Osmolarity, Milliequivalents, and Alligations
4 Chapter 3: Social, Behavioral, and Administrative Sciences
Section 3.1: Saudi Arabian Healthcare System & Public Health Policies Section 3.2: Pharmacoepidemiology & Post-Marketing Drug Surveillance Section 3.3: Pharmacovigilance & Drug Safety Monitoring in Saudi Arabia Section 3.4: Pharmacoeconomic Principles & Cost-Benefit Analysis Section 3.5: Pharmacy Management, Inventory, and Operations Section 3.6: Saudi Pharmacy Law & SFDA Regulations Section 3.7: Biostatistics, Clinical Trial Design & Literature Evaluation Section 3.8: Professional Ethics, Communication, and Dispensing Systems
5 Chapter 4: Clinical Sciences
Section 4.1: Drug Information Services & Evidence-Based Medicine Section 4.2: Clinical Pharmacokinetics & Therapeutic Drug Monitoring (TDM) Section 4.3: Clinical Pharmacogenomics & Personalized Therapeutics Section 4.4: Disease Prevention, Wellness, and Immunization Schedules Section 4.5: Patient Assessment & Physical Examination Interpretation Section 4.6: Clinical Pharmacology: Cardiovascular Disorders Section 4.7: Clinical Pharmacology: Renal & Urological Disorders Section 4.8: Clinical Pharmacology: Respiratory & Pulmonary Disorders Section 4.9: Clinical Pharmacology: Endocrine & Metabolic Disorders Section 4.10: Clinical Pharmacology: Infectious Diseases & Antimicrobial Stewardship Section 4.11: Clinical Pharmacology: Neurological & Psychiatric Disorders Section 4.12: Clinical Pharmacology: Oncology, Immunology, and Hematology Section 4.13: Clinical Pharmacology: Gastrointestinal & Hepatic Disorders Section 4.14: Therapeutic Decision-Making in Special Populations (Geriatrics, Pediatrics, Pregnancy, Lactation)
Section 2.13: Pharmaceutical Calculations: Dilutions and Reconstitution
Key Takeaways Explain This Topic AI
The dilution equation C1V1 = C2V2 represents the mathematical conservation of solute mass when adding solvent to a solution.
Powder volume (displacement volume) is the physical space occupied by dry powder in a vial and must be subtracted to calculate the required diluent volume.
Volumetric infusion rate (mL/hr) is calculated as total volume in mL divided by infusion duration in hours.
IV drip rates (gtt/min) are determined using the drop factor of the administration set: Drip Rate = (Volume in mL * Drop Factor in gtt/mL) / Time in minutes.
Last updated: July 2026
Pharmaceutical Calculations: Dilutions and Reconstitution
Diluting stock solutions, reconstituting dry powders, and calculating intravenous flow rates are daily responsibilities of the clinical and compounding pharmacist. Errors in these calculations can lead to subtherapeutic drug exposure or catastrophic overdoses. This section focuses on the mathematical methods for compounding stock solutions, managing powder displacement volumes, and administering parenteral infusions.
Dilutions of Stock Solutions ( C 1 V 1 = C 2 V 2 C_1V_1 = C_2V_2 C 1 V 1 = C 2 V 2 )
When a solvent (diluent) is added to a concentrated solution, the volume increases and the concentration decreases, but the total mass of the solute remains constant . This relationship is represented by the dilution equation: C 1 ⋅ V 1 = C 2 ⋅ V 2 C_1 \cdot V_1 = C_2 \cdot V_2 C 1 ⋅ V 1 = C 2 ⋅ V 2
where C 1 C_1 C 1 is the initial concentration of the stock solution, V 1 V_1 V 1 is the initial volume of stock solution required, C 2 C_2 C 2 is the final desired concentration, and V 2 V_2 V 2 is the final desired volume ( V 2 = V 1 + Volume of diluent added V_2 = V_1 + \text{Volume of diluent added} V 2 = V 1 + Volume of diluent added ). This relationship also applies to solid dilutions (triturate powders, compounding ointments) using weights instead of volumes ( Q 1 ⋅ C 1 = Q 2 ⋅ C 2 Q_1 \cdot C_1 = Q_2 \cdot C_2 Q 1 ⋅ C 1 = Q 2 ⋅ C 2 ).
Dry Powder Reconstitution and Displacement Volume
Many drugs, particularly beta-lactam antibiotics and chemotherapeutics, are unstable in liquid form and are packaged as dry powders. When reconstituting these vials, the pharmacist must account for the physical space occupied by the powder itself, known as the powder volume or displacement volume ( V p w d V_{pwd} V pw d ): Total Volume ( V t o t a l ) = Volume of Diluent Added ( V d i l u e n t ) + Powder Volume ( V p w d ) \text{Total Volume } (V_{total}) = \text{Volume of Diluent Added } (V_{diluent}) + \text{Powder Volume } (V_{pwd}) Total Volume ( V t o t a l ) = Volume of Diluent Added ( V d i l u e n t ) + Powder Volume ( V pw d )
Clinical Implications of Powder Volume
Low-dose sterile vials: The powder volume is negligible.
High-dose vials (e.g., 10 g 10\text{ g} 10 g bulk packages) or concentrated oral suspensions (e.g., amoxicillin): The powder volume is significant. Failing to subtract the powder volume from the total desired volume when calculating the amount of diluent to add will result in an underdosed, overly diluted solution. This is highly critical for pediatric suspensions where exact dosing is required to prevent treatment failure or toxicity.
Physical Concept: The powder occupies a specific volume because the solid drug crystals displace liquid. When solvent is added, it dissolves the crystals, and the total volume of the final solution is larger than the volume of diluent added.
Infusion Rate and Drip Rate Calculations
Intravenous infusions are administered using electronic infusion pumps (calibrated in mL/hr \text{mL/hr} mL/hr ) or gravity-fed IV lines (calibrated in drops per minute, gtt/min \text{gtt/min} gtt/min ).
1. Volumetric Infusion Rate Infusion Rate (mL/hr) = Total Volume (mL) Time (hr) \text{Infusion Rate (mL/hr)} = \frac{\text{Total Volume (mL)}}{\text{Time (hr)}} Infusion Rate (mL/hr) = Time (hr) Total Volume (mL)
2. Drip Rate (Gravity Infusion)
Gravity-fed lines rely on intravenous tubing sets that have a specified drop factor ( f f f , in gtt/mL \text{gtt/mL} gtt/mL ):
Macrodrip sets: Deliver 10 10 10 , 15 15 15 , or 20 gtt/mL 20\text{ gtt/mL} 20 gtt/mL (typically used for adults).
Microdrip sets: Deliver 60 gtt/mL 60\text{ gtt/mL} 60 gtt/mL (typically used for pediatric patients or low-rate infusions). Note that for a 60 gtt/mL 60\text{ gtt/mL} 60 gtt/mL set, the drip rate in gtt/min \text{gtt/min} gtt/min is numerically equal to the infusion rate in mL/hr \text{mL/hr} mL/hr .
The drip rate is calculated as: Drip Rate (gtt/min) = Volume (mL) ⋅ Drop Factor (gtt/mL) Time (minutes) \text{Drip Rate (gtt/min)} = \frac{\text{Volume (mL)} \cdot \text{Drop Factor (gtt/mL)}}{\text{Time (minutes)}} Drip Rate (gtt/min) = Time (minutes) Volume (mL) ⋅ Drop Factor (gtt/mL)
Clinical Verification and Error Prevention
To prevent serious errors (such as rapid vancomycin administration causing red man syndrome or phenytoin precipitation), institutional settings mandate double-checks of calculations. Reconstituted parenteral medications should be visually checked for complete dissolution and color changes before dispensing.
- Step-by-Step Worked Clinical Calculations
- Example 1: Dilution of a Concentrated Stock Solution
A pharmacist is asked to compound 120 g 120\text{ g} 120 g of a 2 % w/w 2\%\text{ w/w} 2% w/w hydrocortisone cream using a 10 % w/w 10\%\text{ w/w} 10% w/w hydrocortisone stock cream and a vanishing cream base. Calculate the weight of the 10 % 10\% 10% stock cream and base needed.
Use the dilution equation to find the mass of stock cream needed ( Q 1 Q_1 Q 1 ): Q 1 ⋅ C 1 = Q 2 ⋅ C 2 Q_1 \cdot C_1 = Q_2 \cdot C_2 Q 1 ⋅ C 1 = Q 2 ⋅ C 2 Q 1 ⋅ 10 % = 120 g ⋅ 2 % Q_1 \cdot 10\% = 120\text{ g} \cdot 2\% Q 1 ⋅ 10% = 120 g ⋅ 2% Q 1 = 120 ⋅ 2 10 = 24 g Q_1 = \frac{120 \cdot 2}{10} = 24\text{ g} Q 1 = 10 120 ⋅ 2 = 24 g
Calculate the mass of vanishing cream base needed: Weight of base = Q 2 − Q 1 = 120 g − 24 g = 96 g \text{Weight of base} = Q_2 - Q_1 = 120\text{ g} - 24\text{ g} = 96\text{ g} Weight of base = Q 2 − Q 1 = 120 g − 24 g = 96 g
Compounding Procedure: Weigh 24 g 24\text{ g} 24 g of the 10 % 10\% 10% cream and mix geometrically with 96 g 96\text{ g} 96 g of the vanishing cream base.
Example 2: Reconstitution with Powder Displacement
A bulk vial containing 10 g 10\text{ g} 10 g of Ceftazidime powder has a displacement volume of 6.0 mL 6.0\text{ mL} 6.0 mL . How many milliliters of Sterile Water for Injection must the pharmacist add to the vial to achieve a final concentration of 250 mg/mL 250\text{ mg/mL} 250 mg/mL ?
Calculate the total volume needed ( V t o t a l V_{total} V t o t a l ): V t o t a l = Total Drug Mass Target Concentration = 10 , 000 mg 250 mg/mL = 40 mL V_{total} = \frac{\text{Total Drug Mass}}{\text{Target Concentration}} = \frac{10,000\text{ mg}}{250\text{ mg/mL}} = 40\text{ mL} V t o t a l = Target Concentration Total Drug Mass = 250 mg/mL 10 , 000 mg = 40 mL
Calculate the volume of diluent to add ( V d i l u e n t V_{diluent} V d i l u e n t ): V d i l u e n t = V t o t a l − V p w d = 40 mL − 6.0 mL = 34 mL V_{diluent} = V_{total} - V_{pwd} = 40\text{ mL} - 6.0\text{ mL} = 34\text{ mL} V d i l u e n t = V t o t a l − V pw d = 40 mL − 6.0 mL = 34 mL
Action: Inject exactly 34 mL 34\text{ mL} 34 mL of sterile water. Once dissolved, the total volume in the vial will be 40 mL 40\text{ mL} 40 mL , and the concentration will be exactly 250 mg/mL 250\text{ mg/mL} 250 mg/mL .
Example 3: IV Drip Rate Calculation
A physician orders 500 mL 500\text{ mL} 500 mL of D5W containing 2 g 2\text{ g} 2 g of magnesium sulfate to be infused intravenously over 4 hours 4\text{ hours} 4 hours . The administration set has a drop factor of 15 gtt/mL 15\text{ gtt/mL} 15 gtt/mL . Calculate the drip rate in gtt/min \text{gtt/min} gtt/min .
Convert time to minutes: Time = 4 hours ⋅ 60 min/hr = 240 minutes \text{Time} = 4\text{ hours} \cdot 60\text{ min/hr} = 240\text{ minutes} Time = 4 hours ⋅ 60 min/hr = 240 minutes
Calculate the drip rate: Drip Rate = Volume (mL) ⋅ Drop Factor (gtt/mL) Time (min) = 500 mL ⋅ 15 gtt/mL 240 min = 7500 240 = 31.25 gtt/min \text{Drip Rate} = \frac{\text{Volume (mL)} \cdot \text{Drop Factor (gtt/mL)}}{\text{Time (min)}} = \frac{500\text{ mL} \cdot 15\text{ gtt/mL}}{240\text{ min}} = \frac{7500}{240} = 31.25\text{ gtt/min} Drip Rate = Time (min) Volume (mL) ⋅ Drop Factor (gtt/mL) = 240 min 500 mL ⋅ 15 gtt/mL = 240 7500 = 31.25 gtt/min
Clinical Recommendation: The drip rate is set to 31 drops/minute 31\text{ drops/minute} 31 drops/minute .